10x Genomics (TXG) EBITDA (2018 - 2026)
10x Genomics (TXG) EBITDA from Mar 31, 2018 to Mar 31, 2026. The TTM 10x Genomics (TXG) EBITDA is -$570K. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
10x Genomics (TXG) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -99.59% |
| 3 Years TTM | -84.48% |
| 5 Years TTM | -74.31% |
| All Time TTM | -51.71% |
Annual EBITDA change of 10x Genomics (TXG)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$7.09M | -71.40% |
| 2025 | -$25M | -84.38% |
| 2024 | -$159M | -30.95% |
| 2023 | -$230M | +61.19% |
| 2022 | -$143M | +358.01% |
| 2021 | -$31M | -94.01% |
| 2020 | -$520M | +2112.38% |
| 2019 | -$24M | -78.00% |
| 2018 | -$107M | +659.49% |
| 2017 | -$14M | N/A |
Comparison 10x Genomics (TXG) five years EBITDA CAGR with competitors
10x Genomics (TXG) five years EBITDA CAGR is -74.31%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| OPRX | OptimizeRx Corp | 77.72% | -204.59% |
| CCLD | CareCloud Inc | 73.90% | -199.44% |
| CCLDO | CareCloud Inc | 73.90% | -199.44% |
| SY | So-Young International Inc | 39.98% | -153.80% |
| DOCS | Doximity Inc - Class A | 32.10% | -143.19% |
| HQY | Healthequity Inc | 26.05% | -135.06% |
| VEEV | Veeva Systems Inc - Class A | 25.30% | -134.04% |
| HCAT | Health Catalyst Inc | 20.13% | -127.09% |
| SDGR | Schrodinger Inc | 18.03% | -124.26% |
| PRVA | Privia Health Group Inc | 10.68% | -114.37% |
| EVH | Evolent Health Inc - Class A | 9.64% | -112.97% |
| SOPH | SOPHiA Genetics SA | 9.33% | -112.55% |
| HSTM | Healthstream Inc | 9.04% | -112.16% |
| OMCL | Omnicell Inc | 0.63% | -100.85% |
| DRIO | DarioHealth Corp | 0.22% | -100.29% |